Add to Calendar 08/09/2017 08:00 08/09/2017 10:00 America/Los_Angeles Generic Products: Opportunities for Southern California Companies 8 in 10 of the 4.5 billion US prescriptions in 2016 were for generic drugs.  A generic drug is equivalent to a brand-name product in dosage, strength, route of administration, quality, performance, and intended use. A generic drug is required to have the same active ingredient, strength, dosage form, and route of administration as the brand name product, but need not contain the same inactive ingredients.  It must, however, be proven to be bioequivalent to the brand name product.<br>  BIOCOM - McGraw Boardroom Biocom angelaw@biocom.org false MM/DD/YYYY